Arterial-atrial coupling in untreated hypertension

Joanna Jaroch1, Barbara Rzyczkowska, Zbigniew Bociąga

  • 1Department of Cardiology, T. Marciniak Hospital , Wroclaw , Poland.

Blood Pressure
|December 30, 2014
PubMed

Insights

Arterial stiffness contributes to left atrial enlargement in hypertension, independent of other factors. Wave reflection, measured by augmentation index, is a key determinant of left atrial remodeling.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomedical Engineering

Background:

  • Growing interest in arterial-ventricular-atrial coupling.
  • Unclear contribution of arterial stiffness (AS) to left atrial (LA) enlargement.

Purpose of the Study:

  • To determine if carotid AS is associated with LA volume in untreated arterial hypertension, independent of confounders.
  • To investigate the relationship between arterial mechanics and left atrial structural remodeling.

Main Methods:

  • Echocardiography and echo-tracking assessment of AS and wave reflection in 133 patients (107 with hypertension).
  • Measurement of carotid intima-media thickness (IMT) and calculation of LA volume.
  • Multivariate analysis to identify independent determinants of LA volume.

Main Results:

  • Indexed LA volume correlated significantly with age, BMI, pulse pressure, B-type natriuretic peptide, LV volumes, LV mass index (LVMI), wall thickness, mitral inflow patterns, IMT, and augmentation index (AI).
  • LVMI, age, AI, and BMI were identified as independent determinants of indexed LA volume.
  • A significant relationship was found between wave reflection (AI) and LA structural remodeling.

Conclusions:

  • Arterial stiffness, particularly wave reflection, plays a significant role in left atrial enlargement in hypertension.
  • The findings support the hypothesis of arterial-atrial coupling in the context of arterial hypertension.
  • Independent determinants of LA volume include LVMI, age, AI, and BMI.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.9K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
798
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.1K